The FDA limits the use of some monoclonal antibodies treatments
Image Source: npr.org As COVID-19 continues to surge in places across the county, the Food and Drug Administration is curbing the use of two out of three monoclonal antibody treatments available in the U.S. because data shows they aren’t effective against the omicron variant, the agency announced Monday. The two drugs, made by Regeneron and by Eli Lilly, worked well …
The FDA limits the use of some monoclonal antibodies treatments Read More »